Optimizing preparation of normal dendritic cells and bcr-abl+ mature dendritic cells derived from immunomagnetically purified CD14+ cells

Journal of Hematotherapy and Stem Cell Research

Volumn 9, Issue 1, 2000, Pages 95-101

  Dietz, Allan B ^a   Bulur, Peggy A ^a   Erickson, Michele R ^b   Wettstein, Peter J ^b   Litzow, Mark R ^a   Wyatt, William A ^a   Dewald, Gordon W ^a   Tefferi, Ayelew ^a   Pankratz, V Shane ^a   Vuk Pavlović, Stanimir ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BCR ABL PROTEIN; BUSULFAN; CD14 ANTIGEN; CD83 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; MEMBRANE PROTEIN;

ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CELL SEPARATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOADSORPTION; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; PURIFICATION;

ANTIGENS, CD14; CELL DIVISION; COCULTURE TECHNIQUES; CULTURE MEDIA; CULTURE MEDIA, SERUM-FREE; CYTOKINES; DENDRITIC CELLS; FUSION PROTEINS, BCR-ABL; HUMANS; IMMUNOMAGNETIC SEPARATION; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOID, CHRONIC; LEUKOCYTES, MONONUCLEAR; SPECIMEN HANDLING; T-LYMPHOCYTES;

EID: 0034095486     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/152581600319676     Document Type: Article

References (24)

1. Banchereau J and RM Steinman. (1998). Dendritic cells and the control of immunity. Nature 392:245-252.
2. Fernandez NC, A Lozier, C Flament, P Ricciardi-Castagnoli, D Bellet, M Suter, M Perricaudet, T Tursz, E Maraskovsky and L Zitvogel. (1999). Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nature Med 5:405-411.
3. Hsu FJ, C Benike, F Fabnoni, T Lils, D Czerwinski, B Taidi, EG Engleman and R Levy. (1996). Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nature Med 2:52-58.
4. Lotze MT, M Shurin, I Davis, A Amoscato and WJ Storkus. (1997). Dendritic cell-based therapy of cancer. Adv Exp Med Biol 417:551-569.
5. Salgaller ML, BA Tjoa, PA Lodge, H Ragde, G Kenny, A Boynton and GP Murphy. (1998). Dendritic cell-based immunotherapy of prostate cancer. Crit Rev Immunol 18:109-119.
6. Srivastava PK, A Menoret, S Basu, RJ Binder and KL Mc-Quade. (1998). Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world. Immunity 8:657-665.
7. Minev BR, FL Chavez and MS Mitchell. (1998). New trends in the development of cancer vaccines. In Vivo 12:629-638.
8. Reid CD. (1998). The biology and clinical applications of dendritic cells. Transfusion Med 8:77-86.
9. Hart DNJ. (1997). Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 90:3245-3287.
10. Choudhury BA, JC Liang, EK Thomas, L Flores-Romo, QS Xie, K Agusala, S Sutaria, I Sinha, RE Champlin and DF Claxton. (1999). Dendritic cells derived in vitro from acute myelogenous leukemia cells stimulate autologous, antileukemic T-cell responses. Blood 93:780-786.
11. Choudhury A, JL Gajewski, JC Liang, U Popat, DF Claxton,. KO Kliche, M Andreeff and RE Champlin. (1997). Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia. Blood 89:1133-1142.
12. Choudhury A, A Toubert, S Sutaria, D Charron, RE Champlin and DF Claxton. (1998). Human leukemia-derived dendritic cells: ex-vivo development of specific antileukemic cytotoxicity. Crit Rev Immunol 18:121-131.
13. Eibl B, S Ebner, C Duba, G Bock, N Romani, M Erdel, A Gachter, D Niederwieser and G Schuler. (1997). Dendritic cells generated from blood precursors of chronic myelogenous leukemia patients carry the Philadelphia translocation and can induce a CML-specific primary cytotoxic T-cell response. Genes Chromosomes Cancer 20:215-223.
14. Smit WM, M Rijnbeek, CAM van Bergen, RA de Paus, HAW Vervenne, M van de Keur, R Willemze and JHF Falkenburg. (1997). Generation of dendritic cells expressing bcr-abl from CD34-positive chronic myeloid leukemia precursor cells. Hum Immunol 53:216-223.
15. Wang C, H Al-Omar, L Radvanyi, D Bouman, J Squire and H Messner. (1999). Clonal heterogeneity of dendritic cells derived from patients with chronic myeloid leukemia and enhancement of their T-cell stimulatory activity by IFN-α. Exp Hematol 27:1176-1184.
16. Hart DNJ. (1997). Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 90:3245-3287.
17. Labeur MS, B Roters, B Pers, A Mehling, TA Luger, T Schwarz and S Grabbe. (1999). Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage. J Immunol 162: 168-175.
18. Engels FHC, GK Koski, I Bedrosian, SLS Xu, PC Nowell, P Cohen and BJ Czerniecki. (1999). Calcium signaling induces acquisition of dendritic cell characteristics in chronic myelogenous leukemia myeloid progenitor cells. Proc Natl Acad Sci USA 96:10332-10337.
19. Jonuleit H, U Kuhn, G Muller, K Steinbrink, L Paragnik, E Schmitt, J Knop and AH Enk. (1997). Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol. 27:3135-3142.
20. Buno L, WA Wyatt, AR Zinsmeister, J Dietz-Band, RT Silver and GW Dewald. (1998). A special fluorescent in situ hybridization technique to study peripheral blood and assess the effectiveness of interferon therapy in chronic myeloid leukemia. Blood 92:2315-2321.
21. Bender A, M Sapp, G Schuler, R Steinman and N Bhardwai. (1996). Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J Immunol Methods 196:121-135.
22. Romani N, D Reider, M Heuer, S Ebner, E Kampgen, B Eibl, D Niederwieser and G Schuler. (1996). Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Methods 196:137-151.
23. Mannering SI, JL McKenzie and DN Hart. (1998). Optimisation of the conditions for generating human DC-initiated antigen-specific T lymphocyte lines in vitro. J Immunol Methods 219:69-83.
24. Thurner B, C Roder, D Dieckmann, M Heuer, M Kruse, A Glaser, P Keikavoussi, E Kampgen, A Bender and G Schuler. (1999). Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. J Immunol Methods 22: 1-15. 1999.